In Plain Cite

Social media has its own set of opportunities, challenges, and solutions - and even more so when used in medical communications. This episode will examine development of a social media plan, who should create content, understanding compliance, researching your audience, defining your purpose, and more. This episode will also explore where the field is heading next and what may be possible in the future of social media as a communication avenue.

Jennifer Ghith, Global Scientific Publications and Innovations Director at Pfizer. Her areas of focus include artificial intelligence, advancing digital dissemination through social media and closed platforms, and programs aimed at achieving true patient-centricity.

Data privacy is not always a fun topic, but our podcast guest is another fantastic speaker from the Annual Meeting and is enthusiastic and knowledgeable! In this episode, we discuss the implications of international and domestic privacy laws and how they specifically impact medical publications professionals. Of particular importance to our industry is patient privacy in clinical trials and the challenges in protecting their identities.

Jordan Fischer leads the Octillo Legal & Tech Global Data Privacy Team and focuses her practice on international data privacy and cybersecurity and cross-border data management, with an emphasis in European Union data privacy regulations and GDPR. She’s a Lecturer in Cybersecurity at the University of California, Berkeley and a Professor of Law at the Drexel University Thomas R. Kline School of Law. She is also the Director of the Kline School of Law’s Center for Law and Transformational Technology. Jordan is an active speaker, presenter and published expert in data privacy, technology compliance and cybersecurity

The COVID pandemic both accelerated adoption of decentralized clinical trials and highlighted the importance of decentralization in making clinical trials more patient-centric. These trials allow for the continuation of research in challenging periods, as we have seen recently with the global pandemic and in times of war. They don’t, however need to be viewed as only a fall back methodology as there are numerous benefits that make decentralized trials a methodological option and not just an alternative. They have the potential to improve patient engagement in research and certainly help with equity, diversity and inclusion.

Join us for a conversation about decentralized trials with Craig Lipset. Craig is the Co-founder and Co-chair of the Decentralized Trials & Research Alliance which is the industry's largest non-profit collaboration exclusively focused on the global adoption of decentralized research; he is also a board Vice Chair for MedStar Health Research Institute and Vice President of the Foundation for Sarcoidosis Research. Generously sponsored by MedThink SciCom.

Health literacy, health equity, and health disparities are connected, both in practice and in research. Join us for the first episode of InformED’s equity, diversity and inclusion series, and learn from health literacy and communication experts Laurie Myers, Director, Global Health Literacy & Oncology Health Equity at Merck and Stacy Robison, Founder & Owner of CommunicateHealth. Not only will they speak to the vital role of health literacy but also for the need of a higher level of intentionality in the work of health communicators. A list of resources will be shared. 

InformED is generously sponsored by MedThink SciCom.

Join us for a continuation of our conversation with David Barrett, CEO of the American Society of Gene & Cell Therapy, on successfully navigating the changing medical conference landscape. David will speak to designing medical conferences that deliver value and opportunity for all those involved. He will touch on scientific posters, metrics, patient inclusion in medical conferences, and the need to translate complex information into more digestible formats, even for HCPs. Be better prepared for the medical conferences of the future! 

InformED is generously sponsored by MedThink SciCom.

Follow ISMPP on Twitter, LinkedIn and YouTube

Host Robert J. Matheis is currently the President and CEO of the International Society for Medical Publication Professionals.  Previous to this, he was Executive Director and Head of Global Scientific Communications with Celgene Corporation after serving as Senior Director of Evidence Based Medical Communications with Sanofi.  Dr. Matheis has a long tenure within scientific and medical communications and has been an integral part of ISMPP for more than a decade.  

Guest David Barrett, JD, MS, is the CEO of the American Society of Gene & Cell Therapy, the largest society of gene and cell therapy scientists, researchers, and other professionals. ASGCT hosts an annual scientific conference, more than ten additional workshops and symposia each year, and publishes four academic journals within its Molecular Therapy family of journals, among other programs. In this role, David is responsible for the oversight and execution of all facets of ASGCT’s operations, including organizational management and program execution. Since 2016, he has led the Society’s efforts to expand its annual conference, build a legislative and regulatory advocacy function, establish a series of career development awards, and facilitate a robust patient education and advocacy program. In 2020, ASGCT virtual events are projected to attract more than 10,000 individual attendees and its patient education efforts to reach roughly 100,000 viewers.

Medical societies have had to innovate rapidly in light of cancelled conferences during the pandemic. Innovation was accelerated, and the virtual conference emerged. Join us for an insightful conversation with David Barrett, the CEO of the American Society of Gene & Cell Therapy, which is the largest society of gene and cell therapy scientists, researchers, and other professionals. In Part 1 of the discussion, David will speak to successfully navigating the changing medical conference landscape and what the future might hold. What are attendees really looking for? What formats have been most successful for engagement? 

InformED is generously sponsored by MedThink SciCom.

Follow ISMPP on Twitter, LinkedIn and YouTube

Host Robert J. Matheis is currently the President and CEO of the International Society for Medical Publication Professionals.  Previous to this, he was Executive Director and Head of Global Scientific Communications with Celgene Corporation after serving as Senior Director of Evidence Based Medical Communications with Sanofi.  Dr. Matheis has a long tenure within scientific and medical communications and has been an integral part of ISMPP for more than a decade.  

Guest David Barrett, JD, MS, is the CEO of the American Society of Gene & Cell Therapy, the largest society of gene and cell therapy scientists, researchers, and other professionals. ASGCT hosts an annual scientific conference, more than ten additional workshops and symposia each year, and publishes four academic journals within its Molecular Therapy family of journals, among other programs. In this role, David is responsible for the oversight and execution of all facets of ASGCT’s operations, including organizational management and program execution. Since 2016, he has led the Society’s efforts to expand its annual conference, build a legislative and regulatory advocacy function, establish a series of career development awards, and facilitate a robust patient education and advocacy program. In 2020, ASGCT virtual events are projected to attract more than 10,000 individual attendees and its patient education efforts to reach roughly 100,000 viewers.

In a continuation of our previous discussion, let’s talk innovation and digital transformation in medical communications. There is a new sense of urgency to communicate research more rapidly and in innovative ways. But how is this best achieved? Find out in this edition of ISMPP’s InformED. Jennifer Ghith, Global Scientific Publications and Innovations Director at Pfizer will speak to how to keep pace with scientific information and communicate in ways that will meet the new expectations of stakeholders. Don’t miss this conversation moderated by guest host Leslie Rotz, Director of Digital Strategy and Operations at MedThink, SciCom. 

InformED is generously sponsored by MedThink SciCom.

Follow ISMPP on Twitter, LinkedIn and YouTube

Innovative thinking is more important now than ever. What is driving that necessity whether it be within your own organization or more broadly within our industry? What new expectations do stakeholders have? Find out in this edition of InformED where guest host Leslie Rotz, Director of Digital Strategy and Operations at MedThink SciCom talks with Jennifer Ghith, Global Scientific Publications and Innovations Director at Pfizer. 

InformED is generously sponsored by MedThink SciCom.

Follow ISMPP on Twitter, LinkedIn and YouTube

Publication enhancements are all the talk these days. Expanding the reach. Moving beyond publication. There are so many options to enhance the availability of data and improve understanding. Are they ALL worth the investment? Which really work and which are just shiny new toys? Find out in this edition of InformED. Generously sponsored by MedThink SciCom.

Conceptually, providing free open access to scientific and medical research makes intuitive sense. Why would research be maintained behind a paywall when we know that it will further science and benefit patients? On the other hand, it has been challenged that industry sponsored research should not be open access. Also, journals struggle with their operational models in an open access world. Join us for InformED where we tackle the issue of open access during a spirited discussion with Kristen Ratan. 

Kristen is the founder of Strategies for Open Science and has a 20-year history working to accelerate advances in science and research communication. She co-founded the Collaborative Knowledge Foundation (Coko), was the Publisher at the Public Library of Science (PLOS), and also held leadership positions at HighWire Press, Atypon, and BIOSIS. Kristen is on the board of the American Institute of Physics Publishing, the Code for Science and Society, and ASAPbio. Generously sponsored by MedThink SciCom.